What is the most likely diagnosis and recommended evaluation for a patient with ferritin 413 ng/mL, normal serum iron, normal total iron‑binding capacity (TIBC) and unsaturated iron‑binding capacity (UIC), reticulocyte count 0.018, peripheral smear showing microscopic hypochromic red cells with a few ovalocytes, and a platelet count of 109 ×10⁹/L?

Anemia of Chronic Disease with Possible Functional Iron Deficiency and Thrombocytopenia

This patient most likely has anemia of chronic disease (ACD) with possible concurrent functional iron deficiency, and the thrombocytopenia requires urgent investigation for an underlying inflammatory or systemic disorder.

Most Likely Diagnosis

The laboratory pattern is highly suggestive of anemia of chronic disease with functional iron deficiency:

• Ferritin 413 ng/mL: Elevated, indicating either inflammation or adequate iron stores 1, 2
• Normal serum iron, TIBC, and UIBC: This combination with elevated ferritin is classic for ACD where iron is sequestered in storage but not available for erythropoiesis 2
• Hypochromic red cells: Indicates inadequate iron delivery to developing erythrocytes despite stored iron 1, 3
• Elevated reticulocyte count (0.018 = 1.8%): Suggests bone marrow response to anemia, though may be inadequate for the degree of anemia 4
• Thrombocytopenia (109 × 10⁹/L): Concerning for systemic disease affecting multiple cell lines

Critical Interpretation of Iron Studies

The ferritin level of 413 ng/mL is the key discriminator here. According to British Society of Gastroenterology guidelines, ferritin >150 ng/mL is unlikely to occur with absolute iron deficiency, even in the presence of inflammation 1. However, the European consensus on inflammatory bowel disease states that in the presence of inflammation, ferritin >100 ng/mL with transferrin saturation <16% indicates ACD 2.

The normal TIBC and UIBC with normal serum iron but elevated ferritin strongly suggests functional iron deficiency - iron is trapped in reticuloendothelial stores and cannot be mobilized for erythropoiesis due to inflammatory blockade 2, 3.

Immediate Evaluation Required

1. Assess for Inflammation/Infection

• CRP and ESR: Essential to determine if ferritin elevation is due to acute-phase reaction 2
• These markers are independent of iron metabolism and will clarify whether inflammation is driving the picture 2

2. Calculate Transferrin Saturation

While you report normal iron and TIBC, calculate the actual transferrin saturation percentage (serum iron ÷ TIBC × 100):

• If TSAT <16% with ferritin >100 ng/mL = ACD 2
• If TSAT <20% = likely functional iron deficiency 3, 5

3. Investigate Thrombocytopenia

The platelet count of 109 × 10⁹/L is abnormal and suggests:

• Bone marrow suppression from chronic disease
• Autoimmune process
• Splenic sequestration
• Drug effect
• Hematologic disorder

Check complete blood count with differential, peripheral smear review by hematologist, and consider bone marrow evaluation if other cell lines are affected 4.

4. Screen for Underlying Systemic Disease

Given the constellation of findings, evaluate for:

• Inflammatory bowel disease (most common cause of this pattern) 2
• Chronic kidney disease: Check creatinine, eGFR 3, 4
• Autoimmune conditions: ANA, rheumatoid factor
• Chronic infection: HIV, hepatitis panel
• Malignancy: Age-appropriate cancer screening
• Liver disease: LFTs, hepatitis serologies 6, 7

5. Advanced Iron Studies (if available)

• Soluble transferrin receptor (sTfR): Elevated in true iron deficiency, normal/low in ACD 2, 5
• Reticulocyte hemoglobin content (CHr or RET-He): More accurate for functional iron availability than ferritin in inflammatory states 5, 4, 8
• Percentage hypochromic red cells: >10% indicates iron-deficient erythropoiesis 3, 4

Common Pitfalls to Avoid

1. Do not assume iron overload based on ferritin alone - ferritin is an acute-phase reactant and can be elevated without true iron excess 3, 9

2. Do not start iron supplementation without determining inflammatory status - in pure ACD with inflammatory blockade, iron supplementation may not be effective and could worsen outcomes 2

3. Do not ignore the thrombocytopenia - this suggests a systemic process affecting multiple cell lines and requires hematology evaluation 4

4. Do not rely on ferritin cutoffs from healthy populations - in inflammatory states, the lower limit of normal ferritin for adequate iron stores increases to 100 ng/mL 2

Management Algorithm

Step 1: Measure CRP/ESR to confirm inflammation

Step 2: If inflammation present (elevated CRP/ESR):

• Ferritin 30-100 ng/mL = mixed iron deficiency + ACD 2
• Ferritin >100 ng/mL + TSAT <16% = pure ACD 2
• Ferritin >100 ng/mL + TSAT >16% = ACD without iron deficiency 2

Step 3: Treat underlying inflammatory condition as primary therapy 2

Step 4: Consider iron supplementation (preferably IV) if TSAT <20% despite ferritin >100 ng/mL, as this represents functional iron deficiency 2, 5

Step 5: Investigate and manage thrombocytopenia concurrently

The priority is identifying and treating the underlying inflammatory or systemic disease causing this pattern, as treating anemia alone without addressing the root cause will be ineffective 2.